AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Olaparib in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Lynparza 100 mg Tablets_ Tablet | A4-101645 | AstraZeneca Nigeria Limited | active | 28 Oct 2030 |
Olaparib — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Olaparib, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Olaparib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.